Who
Timothy K. Lu
CEO
Company insider
Files Form 4 as: CEO, Senti Biosciences Holdings.
In numbers
- Trades disclosed
- 11
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $18K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Feb 2023
- Last trade
- 9 Mar 2026
- Last filed
- 11 Mar 2026
Companies traded
Activity over time
1 Feb 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Mar 2026filed 11 Mar 2026 | SNTI Senti Biosciences HoldingsBiotechnology | SEC FORM 4 Code F | —80,666 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | SNTI Senti Biosciences HoldingsBiotechnology | SEC FORM 4 Code F | —80,666 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | SNTI Senti Biosciences HoldingsBiotechnology | SEC FORM 4 Code F | —4,191 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | SNTI Senti Biosciences HoldingsBiotechnology | SEC FORM 4 Code F | —4,191 at $0.00 | filing |
| 7 Mar 2025filed 10 Mar 2025 | SNTI Senti Biosciences HoldingsBiotechnology | SEC FORM 4 Code A | —642,358 at $0.00 | filing |
| 6 Mar 2025filed 10 Mar 2025 | SNTI Senti Biosciences Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,927,073 at $0.00 | filing |
| 6 Feb 2025filed 6 Feb 2025 | SNTI Senti Biosciences HoldingsBiotechnology | SEC FORM 4 Sold | $2,376545 at $4.36 | filing |
| 4 Feb 2025filed 6 Feb 2025 | SNTI Senti Biosciences HoldingsBiotechnology | SEC FORM 4 Sold | $16K3,922 at $4.07 | filing |
| 1 Feb 2024filed 2 Feb 2024 | SNTI Senti Biosciences Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —459,000 at $0.00 | filing |
| 1 Feb 2024filed 2 Feb 2024 | SNTI Senti Biosciences HoldingsBiotechnology | SEC FORM 4 Code A | —306,000 at $0.00 | filing |
| 1 Feb 2023filed 2 Feb 2023 | SNTI Senti Biosciences Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —630,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.